CHEMOTHERAPY-INDUCED METABOLIC STRESS IN IDH1 MUTANT GLIOMAS

被引：0
|
作者：
Tateishi, Kensuke [1 ]
Wakimoto, Hiroaki [2 ,3 ]
Higuchi, Fumi [1 ]
Miller, Julie [1 ]
Koerner, Mara V. A. [1 ]
Lelic, Nina [1 ]
Shankar, Ganesh [1 ]
Tanaka, Shota [1 ]
Curry, William T. [1 ]
Fisher, David E. [1 ]
Batchelor, Tracy T. [1 ]
Iafrate, A. John [1 ]
Chi, Andrew S. [4 ]
Cahill, Daniel P. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
[4] NYU, Langone Med Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-37
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [31] Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity
    Xie, Xiaoling
    Baird, Daniel
    Bowen, Kimberly
    Capka, Vladimir
    Chen, Jinyun
    Chenail, Gregg
    Cho, YoungShin
    Dooley, Julia
    Farsidjani, Ali
    Fortin, Pascal
    Kohls, Darcy
    Kulathila, Raviraj
    Lin, Fallon
    McKay, Daniel
    Rodrigues, Lindsey
    Sage, David
    Toure, B. Barry
    van der Plas, Simon
    Wright, Kirk
    Xu, Ming
    Yin, Hong
    Levell, Julian
    Pagliarini, Raymond A.
    STRUCTURE, 2017, 25 (03) : 506 - 513
  • [32] IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA
    Fack, F.
    Hochart, G.
    Oudin, A.
    Keunen, O.
    Leenders, W. P.
    Gottlieb, E.
    Bjerkvig, R.
    Stauber, J.
    Niclou, S. P.
    NEURO-ONCOLOGY, 2014, 16
  • [33] PLK1 INHIBITION ENHANCES TEMOZOLOMIDE EFFICACY IN IDH1 MUTANT GLIOMAS
    Bahassi, El Mustapha
    Koncar, Robert
    Chu, Zhengtao
    Qi, Chiaoyang
    Romick-Rosendale, Lindsey
    Wells, Susanne
    Chan, Timothy
    NEURO-ONCOLOGY, 2016, 18 : 68 - 68
  • [34] IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA
    Niclou, Simone P.
    Fack, Fred
    Hochart, Guillaume
    Oudin, Anais
    Leenders, William
    Gottlieb, Eyal
    Bjerkvig, Rolf
    Stauber, Joachim
    NEURO-ONCOLOGY, 2014, 16
  • [35] Spikes induced by IDH1-mutant gliomas
    Abounader, Roger
    Wright, Karen
    Bhat, Krishna
    Chamberlain, Marc
    Purow, Benjamin
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2017, 19 (10) : 1295 - 1296
  • [36] Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies
    Ikota, Hayato
    Nobusawa, Sumihito
    Arai, Hideo
    Kato, Yukinari
    Ishizawa, Keisuke
    Hirose, Takanori
    Yokoo, Hideaki
    BRAIN TUMOR PATHOLOGY, 2015, 32 (04) : 237 - 244
  • [37] YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas
    Patrick, Shruti
    Gowda, Pruthvi
    Lathoria, Kirti
    Suri, Vaishali
    Sen, Ellora
    JOURNAL OF CELL SCIENCE, 2021, 134 (22)
  • [38] PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
    Koncar, Robert F.
    Chu, Zhengtao
    Romick-Rosendale, Lindsey E.
    Wells, SusanneI.
    Chan, Timothy A.
    Qi, Xiaoyang
    Bahassi, El Mustapha
    ONCOTARGET, 2017, 8 (09) : 15827 - 15837
  • [39] Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies
    Hayato Ikota
    Sumihito Nobusawa
    Hideo Arai
    Yukinari Kato
    Keisuke Ishizawa
    Takanori Hirose
    Hideaki Yokoo
    Brain Tumor Pathology, 2015, 32 : 237 - 244
  • [40] PHASE 1 STUDY OF FT-2102, AN INHIBITOR OF MUTANT IDH1, IN PATIENTS WITH RELAPSED/REFRACTORY IDH1 MUTANT GLIOMAS: PRELIMINARY SAFETY AND CLINICAL ACTIVITY
    De la Fuente, Macarena I.
    Colman, Howard
    Rosenthal, Mark
    Van Tine, Brian A.
    Fonkem, Ekokobe
    Walbert, Tobias
    Milhem, Mohammed
    Lipford, Kate
    Forsyth, Sanjeev
    Guichard, Sylvie
    Brevard, Julie
    Mikhailov, Yelena
    Thomson, Blythe
    Monga, Varun
    NEURO-ONCOLOGY, 2019, 21 : 25 - 25
12345